Jorge Castillo, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the clinical presentations, complications, and survival outcomes of patients with familial Waldenström’s macroglobulinemia (WM), highlighting how these patients have an increased risk of certain complications, including Bing-Neel Syndrome (BNS) and amyloidosis, but no difference in survival outcome compared to other forms of WM.
This interview took place at the Twelfth Annual Meeting of the Society of Hematologic Oncology (SOHO 2024) congress in Houston, TX.